{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-25-000046","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.202526+00:00","generated_at":"2026-05-17T09:51:07.961818+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CooperCompanies Reports Q3 2025 Revenue of $1.0603B, Up 6%; Non-GAAP EPS $1.10, Up 15%","bullets":["Revenue grew 6% to $1,060.3 million; CooperVision up 6% to $718.4M, CooperSurgical up 4% to $341.9M.","GAAP diluted EPS fell 6% to $0.49; non-GAAP diluted EPS rose 15% to $1.10, driven by margin improvement.","Free cash flow was $164.6 million, with operating cash flow of $261.5M and capex of $96.9M.","Company repurchased $52.1M of stock (~724,300 shares) at average price of $71.97; $163.6M remaining.","Raised FY2025 non-GAAP EPS guidance to $4.08-$4.12; Q4 revenue expected $1.049B-$1.069B."],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-25-000046","json":"https://secwatch.observer/filing/0000711404-25-000046.json","markdown":"https://secwatch.observer/filing/0000711404-25-000046.md","text":"https://secwatch.observer/filing/0000711404-25-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140425000046/0000711404-25-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140425000046/coo-20250827.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-17T09:51:07.961818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}